| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.7M | +224.7% |
| R&D Expense | $60.2M | -20.3% |
| SG&A Expense | $29.5M | +21.3% |
| Operating Income | -$76.4M | +20.9% |
| Pre-tax Income | -$72.7M | +24.4% |
| Income Tax | $7K | -90.0% |
| Net Income | -$72.7M | +24.5% |
| EPS (Basic) | -$0.76 | +38.7% |
| EPS (Diluted) | -$0.76 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $141.4M | -32.4% |
| Accounts Receivable | $0 | — |
| Current Assets | $158.9M | -28.8% |
| Total Assets | $183.0M | -25.8% |
| Current Liabilities | $37.3M | +26.5% |
| Total Liabilities | $42.8M | -17.8% |
| Stockholders' Equity | $140.2M | -27.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$79.7M | -43.1% |
| Capital Expenditures | $677K | -10.2% |
| Investing Cash Flow | -$808K | -708.0% |
| Financing Cash Flow | $6.8M | -96.5% |
| Free Cash Flow | -$80.3M | -42.4% |
| +38.7% |